Desmin is a protein found inside muscle cells that helps hold their internal structure together. Pathologists detect desmin in tissue samples using a stain called immunohistochemistry, and its presence or absence helps identify what kind of cell a tumor or tissue is made of. In the asbestos context, desmin is one of several markers used to tell mesothelioma cells apart from normal reactive cells and from other cancers.
Origin
The protein was first described in the 1970s by Lazarides and Hubbard, who named it from the Greek desmos, meaning "bond" or "link," because it links the internal scaffolding of muscle cells. It became a routine immunohistochemistry marker in surgical pathology in the 1980s.
Significance in Asbestos Context
One of the hardest calls a pathologist must make in a suspected mesothelioma case is distinguishing true cancer cells from benign "reactive" mesothelial cells that are simply inflamed or irritated. Desmin staining helps with this: benign reactive mesothelial cells often stain positive for desmin, while malignant mesothelioma cells usually stain negative or only weakly. Pathologists rarely rely on desmin alone. It is used as part of a panel alongside markers like calretinin, WT-1, BAP1, and EMA. For patients, this matters because an accurate mesothelioma diagnosis is the foundation of both treatment planning and any legal claim, and the markers listed on the pathology report (including desmin) are part of how that diagnosis is defended if challenged.
Example Sentence
The pathology report noted that the tumor cells were negative for desmin and positive for calretinin, supporting the diagnosis of epithelioid mesothelioma rather than a benign reactive process.
Related Terms
Immunohistochemistry, Calretinin, BAP1, Reactive Mesothelial Hyperplasia, Epithelioid Mesothelioma, WT-1
Notes
- Ask your oncologist or pathologist for a copy of the full immunohistochemistry panel from your biopsy. Desmin should be one of several markers listed, and the pattern of positives and negatives is what supports the diagnosis.
- If your initial biopsy was ambiguous (for example, "atypical mesothelial proliferation"), request a second opinion from a mesothelioma specialty center such as the International Mesothelioma Panel or a major academic pathology department; desmin and BAP1 results are often re-reviewed.
- Preserve all pathology slides and tissue blocks. These are the physical evidence behind your diagnosis and may be needed for both treatment decisions and any legal claim.
- Desmin staining alone does not confirm or rule out mesothelioma; do not interpret a single marker without the full panel and clinical context.
In the research library
47 studies in our medical research library mention Desmin in the title or abstract. Among the most cited:
- Comparative immunohistochemical staining for desmin and muscle-specific actin. A study of 576 casesS. Rangdaeng, L.D. Truong, 1991 · American Journal of Clinical Pathology · cited 124 times
- Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cellsH. Minato, N. Kurose, M. Fukushima, et al, 2014 · American Journal of Clinical Pathology · cited 49 times
- The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytologyT.S. Hyun, M. Barnes, Z.L. Tabatabai, 2012 · Acta Cytologica · cited 41 times
- Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusionsS. Önder, E. Özogul, D. Koksal, et al, 2019 · Cytopathology · cited 16 times
- Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: an evidence-based approachM. Kuperman, R.R. Florence, L. Pantanowitz, et al, 2013 · Diagnostic Cytopathology · cited 9 times
The journals that publish most on it: Histopathology (5), Pathology International (4), American Journal of Clinical Pathology (3).
Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.